Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2004
12/02/2004WO2004104550A2 Rapid and specific detection of enterobacter sakazakii
12/02/2004WO2004104230A1 Reducing microarray variation with internal reference spots
12/02/2004WO2004104229A2 Internal control nucleic acid molecule for nucleic acid amplification systems
12/02/2004WO2004104228A1 Microfluidic protein crystallography
12/02/2004WO2004104227A1 Methods and compositions for diagnosing and treating disorders involving angiogenesis
12/02/2004WO2004104226A1 Susceptibility gene for alzheimer's disease
12/02/2004WO2004104225A1 Diagnosis and prediction of parkinson’s disease
12/02/2004WO2004104224A2 Markers for lxr activation
12/02/2004WO2004104223A1 Method for the covalent immobilisation of probe biomolecules on organic surfaces
12/02/2004WO2004104220A2 Use of a biotinylated polypeptide for determining the activity of protein-phosphorylating enzymes
12/02/2004WO2004104219A1 Mass-based toxin assay and substrates therefor
12/02/2004WO2004104218A1 Diagnostics and therapeutics for diseases associated with x-prolyl aminopeptidase (aminopeptidase p) 1 (xpnpep1)
12/02/2004WO2004104217A2 Protein kinase c zeta as a drug target for arthritis and other inflammatory diseases
12/02/2004WO2004104216A2 Diagnostics and therapeutics for diseases associated with dipeptidylpeptidase iv (dpp4)
12/02/2004WO2004104215A2 Diagnostics and therapeutics for diseases associated with dipeptidylpeptidase 7 (dpp7)
12/02/2004WO2004104214A2 Methods and devices for multiplexing amplification reactions
12/02/2004WO2004104212A2 Molecular signature and assay for fluoroquinoline resistance in bacillus anthracis
12/02/2004WO2004104211A2 Method for detecting toxic and non-toxic cyanobacteria
12/02/2004WO2004104203A1 Method of measuring glycolated hemoglobin a1c, enzyme to be used therefor and process for producing the same
12/02/2004WO2004104199A2 Modulation of gene expression using dna-dna hybrids
12/02/2004WO2004104196A1 Buffer composition
12/02/2004WO2004104189A1 New enterovirus, vaccines, medicaments and diagnostic kits
12/02/2004WO2004104181A2 Nucleic acid processing methods, kits and devices
12/02/2004WO2004104179A2 Method for isolating and cloning high molecular weight polynucleotide molecules from the environment
12/02/2004WO2004104177A2 Methods for localizing target molecules in a flowing fluid sample
12/02/2004WO2004104176A2 Method for the identification of inhibitors of ornithine carbamoyltransferase, ketol-acid reductoisomerase, and fungal pathogenicity-conferring gene as antibiotics
12/02/2004WO2004104172A2 Hybridization-mediated analysis of polymorphisms
12/02/2004WO2004104171A2 Ranbp2 as modifier of the pten/igf pathway and methods of use
12/02/2004WO2004104161A2 Methods and systems for identifying naturally occurring antisense transcripts and methods, kits and arrays utilizing same
12/02/2004WO2004104070A1 Permselective structurally robust membrane material
12/02/2004WO2004104037A1 Method for screening inhibitors of the gamma-secretase
12/02/2004WO2004103939A2 Assay method and apparatus
12/02/2004WO2004103547A1 Device for holding and detecting substance libraries
12/02/2004WO2004103512A2 Method and system for electrokinetic, preparative sample separation in high-surface-area separation channels with non-convex cross sections
12/02/2004WO2004103406A1 Therapeutic composition for disease accompanied by decrease or increase of platelet
12/02/2004WO2004103368A1 Treatment of tay sachs or sandhoff diseases by enhancing hexosaminidase activity
12/02/2004WO2004103316A2 Orp9, a novel therapeutic target for increasing hdl levels
12/02/2004WO2004103269A2 Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of the genus borrelia
12/02/2004WO2004103268A2 Intracellular production of specific rna molecules by splicing
12/02/2004WO2004092418A3 Global amplification using a randomly primed composite primer
12/02/2004WO2004087868A3 Dna polymerase fusions and uses thereof
12/02/2004WO2004087863A3 Non-invasive prenatal genetic diagnosis using transcervical cells
12/02/2004WO2004082569A3 Diagnostics and therapeutics for diseases associated with dopamine receptor d3 (drd3)
12/02/2004WO2004081566A3 Method and device for detecting biomolecules
12/02/2004WO2004081521A3 Methods for direct detection of individual methotrexate metabolites
12/02/2004WO2004081174A3 Marker for detecting mesenchymal stem cell and method of distinguishing mesenchymal stem cell using the marker
12/02/2004WO2004079007A3 Time-lapse cell analysis method
12/02/2004WO2004067768A3 Improved method for the detection of proteolytic enzymes
12/02/2004WO2004067702B1 Methods, oligonucleotides and kits for the identification of mycobacterium in a sample
12/02/2004WO2004058945A3 Comparative genomic hybridization assays using immobilized oligonucleotide features and compositions for practicing the same
12/02/2004WO2004050825A3 Protein synthesis monitoring (psm)
12/02/2004WO2004044218A3 Methods and materials for examining pathways associated with glioblastoma progression
12/02/2004WO2004044128A3 An associative analysis of gene expression array data
12/02/2004WO2004042064A3 Disorders of lipid metabolism
12/02/2004WO2004027020A3 Identification of a phage associated lytic enzyme to rapidly and specifically detect and kill bacillus anthracis
12/02/2004WO2004023490A3 Fluid delivery for scanning probe microscopy
12/02/2004WO2004014212A3 Self-assembled muscle-powered microdevices
12/02/2004WO2004013308A3 Maxs as modifiers of the axin pathway and methods of use
12/02/2004WO2004012585A3 Electrophysiology assay methods
12/02/2004WO2004009833A3 Test systems for detecting inhibitors of inositol phosphate kinases and use of these inhibitors for the prophylaxis or therapy of proliferative diseases
12/02/2004WO2004009765A3 Strategies for gene expression analysis
12/02/2004WO2003095667A3 Autoimmune conditions and nadph oxidase defects
12/02/2004WO2003089605A3 Method of creating a library of bacterial clones with varying levels of gene expression
12/02/2004WO2003085377A3 Novel pancortin-pablo protein interactions and methods of use thereof
12/02/2004WO2003078465A8 The use of an epitope of vascular endothelial growth factor receptor kdr/flk-1
12/02/2004WO2003073817A3 Rapid and sensitive detection of cells and viruses
12/02/2004WO2003073066A3 Reagents and methods for assaying bacillus anthracis lethal factor protease
12/02/2004WO2003064665A3 Viral vector
12/02/2004WO2003044161A3 Gene amplification and overexpression in cancer
12/02/2004WO2003027240A3 Rhesus monkey, dog and ferret melanin-concentrating hormone type 1 receptor
12/02/2004WO2003014298A3 Full-length prostate selective polynucleotides and polypeptides
12/02/2004WO2003006482A3 Use of specific t2r taste receptors to identify compounds that block bitter taste
12/02/2004WO2002078512A8 Blood glucose tracking apparatus and methods
12/02/2004WO2002068583A3 Enzymes having dehalogenase activity and methods of use thereof
12/02/2004WO2002051981A3 Defects in periaxin associated with myelinopathies
12/02/2004US20040244068 Determining the life-stage of companion animals using immune status indicators or measuring cell populations
12/02/2004US20040243318 Microbe examining device and method
12/02/2004US20040242601 Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis
12/02/2004US20040242532 Drug screening for and use of enzyme inhibitors of ADP-glucose pyrophosphorylase and glycogen synthase; adenosine alpha -P-boranodiphosphoglucose; bactericides
12/02/2004US20040242521 Thio-siRNA aptamers
12/02/2004US20040242515 Trp1, mct, or ftz-f1 homologous proteins involved in the regulation of energy home-ostasis
12/02/2004US20040242512 Novel vectors for animal cells and utilization thereof
12/02/2004US20040242511 Method
12/02/2004US20040242510 Methods and compositions for detecting colon cancers
12/02/2004US20040242487 Identifying a subject in need of inhibiting appetite or weight gain and administering an effective amount of an antagonist of melanocyte concentrating hormone (MCH) to subject, wherein antagonist binds an MCH receptor
12/02/2004US20040242484 Specific polypeptides, useful as nematocides
12/02/2004US20040242462 Detecting that individual's Tob gene, transcript and/or protein and comparing with normal Tob gene, transcript and/or protein, differences present indicating that the probability of that individual suffering from amnesia
12/02/2004US20040241880 Enhancing fluorescent signal of microarrays via acetonitrile/degradation inhibitor deposition; nucleic acid analysis
12/02/2004US20040241869 Multicompartment device for monitoring temperature changes in chemical and biochemical reactions; noninvasive electrothermometry; screening, identifying, and ranking drug candidates
12/02/2004US20040241853 Introducing one or more mutations into a template double-stranded polynucleotide via hybridization, replication and amplification of random genomic double stranded and heterozygous oligonucleotides sequences; genomics and directed evolution
12/02/2004US20040241850 Glucosyltransferases which glucosylate abscisic acid
12/02/2004US20040241848 Method of detecting microorgan ISMS using labelled electron acceptors
12/02/2004US20040241830 Screening drugs targeting the D-alanine branch of mycobacterial peptidoglycan biosynthesis; bioassay; microbiocides; genetic vaccines
12/02/2004US20040241828 Automated process for detecting pathogenic organisms in water
12/02/2004US20040241826 Mycobacterial antigens expressed during latency
12/02/2004US20040241825 Methods for generating libraries of therapeutic bacteriophages having desired safety characteristics and methods for labeling and monitoring bacteriophages
12/02/2004US20040241824 Identifying nucleotide sequences polymorphisms and/orvariations between methicillin resistant and sensitive bacteria; diagnosis and treatment of infection; using polymorphic sequences to distinguish between bacterial phenotypes; genomics
12/02/2004US20040241823 Method and kit for the diagnosis of ulcerative colitis
12/02/2004US20040241818 Assay
12/02/2004US20040241811 Enzymatic method of producing 4-O-B-D-galactopyranosyl-D-xylose, 4-O-B-D-galactopyranosyl-D-xylose obtained using said method, compositions contain same and the use thereof in evaluating intestinal lactase